PARALLEL SESSION 2 - CIRCULATION 1
Tracks
SARAJEVO
| Wednesday, October 22, 2025 |
| 9:00 AM - 11:00 AM |
Overview
PDA, are we there yet? Early and late management approaches
Details
Moderators: Silvia Martini, Italy and Elisabeth Kooi, the Netherlands
09.00 - 09.30
Hemodynamically Significant Patent Ductus Arteriosus in premature babies, when and how to treat it?
Yogen Singh, USA
09.30 – 10.00
Neonatal transcather closure of a PDA, a new era
Carles Bautista, UK
10.00 – 10.15 454
Transcatheter device occlusion of the patent ductus arteriosus effects cerebral blood flow in premature neonates: A pilot study using frequency-domain near-infrared spectroscopy and diffuse correlation spectroscopy during device placement Wievineke Apers (Netherlands)
10.15 – 10:30 793
Machine Learning Can Identify High Volume Patent Ductus Arteriosus in Preterm Neonates
Amy Hobson (United States)
10.30 – 10:45 252
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus (PDA) for preterm infants: update of a Cochrane Systematic Review
Souvik Mitra (Canada)
10.45 - 11.00 602
When Duration Matters: PDA and Respiratory Support as Combined Risk Factors for BPD Emel Okulu (Turkiye)
09.00 - 09.30
Hemodynamically Significant Patent Ductus Arteriosus in premature babies, when and how to treat it?
Yogen Singh, USA
09.30 – 10.00
Neonatal transcather closure of a PDA, a new era
Carles Bautista, UK
10.00 – 10.15 454
Transcatheter device occlusion of the patent ductus arteriosus effects cerebral blood flow in premature neonates: A pilot study using frequency-domain near-infrared spectroscopy and diffuse correlation spectroscopy during device placement Wievineke Apers (Netherlands)
10.15 – 10:30 793
Machine Learning Can Identify High Volume Patent Ductus Arteriosus in Preterm Neonates
Amy Hobson (United States)
10.30 – 10:45 252
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus (PDA) for preterm infants: update of a Cochrane Systematic Review
Souvik Mitra (Canada)
10.45 - 11.00 602
When Duration Matters: PDA and Respiratory Support as Combined Risk Factors for BPD Emel Okulu (Turkiye)
Speaker
Doctor Wievineke Apers
Transcatheter device occlusion of the patent ductus arteriosus effects cerebral blood flow in premature neonates: A pilot study using frequency-domain near-infrared spectroscopy and diffuse correlation spectroscopy during device placement.
Dr. Amy Hobson
Physician
University Of Iowa
Machine Learning Can Identify High Volume Patent Ductus Arteriosus in Preterm Neonates
Dr. Souvik Mitra
Physician
University Of British Columbia
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus (PDA) for preterm infants: update of a Cochrane Systematic Review
Prof. Dr. Emel Okulu
MD
Ankara University Faculty Of Medicine
When Duration Matters: PDA and Respiratory Support as Combined Risk Factors for BPD
The Organising Secretariat
Any questions or comments please contact us at info@jenscongress.eu
Follow us to stay updated!
